On March 25, the American Association for Cancer Research (AACR) announced that John E. Dick, PhD, Fellow of the AACR Academy, would receive the inaugural AACR Award for Outstanding Achievement in Blood Cancer Research during the AACR Annual Meeting, April 8-13 in New Orleans. The AACR established this award to recognize an individual for meritorious achievements and contributions to basic, translational, or clinical research related to blood cancer or associated disorders such as myelodysplastic syndrome or myeloproliferative neoplasms. Funding for this new award is provided by an unrestricted educational grant from Pharmacyclics, an AbbVie Company, and Janssen Biotech, Inc. The award presentation, and other meeting presentations/sessions, can be viewed on the virtual platform by registered meeting participants through July 13, 2022. Registration can be done here. Over 19,000 scientists and physicians registered for this premier cancer conference, with ~80% (~15,200) attending in person and ~20% (~3,800) attending virtually. The AACR has over 50,000 members worldwide.